Ingenix

Ingenix is a proprietary multimodal and multiscale generative AI co-pilot designed for clinical development, enabling accurate simulation of clinical trials on digital twins. The platform integrates biological and medical knowledge across multiple modalities such as text, graphics, bioimaging, 3D structures, sequences, and time series, using chain-of-thought prompting. Ingenix's AI foundation model comprehends multiple biological scales from molecular to population levels, operating significantly faster than other molecular docking models to simulate drug interactions across the human proteome. The company targets pre-clinical development, strategy, and clinical development teams in pharma, offering granular predictions of clinical endpoints and adverse events, thus addressing the high failure rate and patent cliff challenges in the pharmaceutical industry. Ingenix differentiates itself by combining AI-native expertise with deep biological understanding and leveraging increasing availability of high-quality multi-omics and health data to revolutionize AI-powered drug development.